← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3132)
- Comparative Evaluation of Anti-Fibrotic Effect of Tissue Specific Mesenchymal Stem Cells Derived Extracellular Vesicles for the Amelioration of CCl4 Induced Chronic Liver Injury. (2022/03/01) ♡
- Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway. (2022/03/01) ♡
- Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis. (2022/03/01) ♡
- Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis. (2022/03/01) ♡
- Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial. (2022/03/01) ♡
- Clinical Outcomes of Transcatheter Arterial Embolization Using N-Butyl-2-Cyanoacrylate (NBCA) in Cirrhotic Patients. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of Refractory Varicose Bleed in Cirrhosis. (2022/03/01) ♡
- Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gallstone Disease in Cirrhosis Pathogenesis and Management. (2022/03/01) ♡
- Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Familial Intrahepatic Cholestasis: Need for Genetic Analysis Before Liver Transplantation. (2022/03/01) ♡
- Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Center Experience in 91 Patients. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Barrier and Microbiota in Cirrhosis. (2022/03/01) ♡
- Giant Cell Hepatitis in Copper Toxicosis. (2022/03/01) ♡
- Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis. (2022/03/01) ♡
- A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. (2022/03/01) ♡
- Spontaneous Rupture of Hepatocellular Carcinoma: New Insights. (2022/03/01) ♡
- Hepatogenous Diabetes - A Report from Central India. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatic Regeneration in Cirrhosis. (2022/03/01) ♡
- Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease. (2022/03/01) ♡
- Principles, Interpretation, and Evidence-Based Role of Viscoelastic Point-of-Care Coagulation Assays in Cirrhosis and Liver Failure. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Adapting the Utility of Lipiodol CT in Treating Small Hepatocellular Carcinoma. (2022/03/01) ♡
- Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Living-Donor Liver Transplantation for Late-Onset Lysosomal Acid Lipase Deficiency. (2022/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hepatic Artery Vasospasm Masquerading as Hepatic Artery Thrombosis in a Case of Deceased Donor Liver Transplant. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fatigue in Cirrhosis. (2022/03/01) ♡
- Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation. (2022/03/01) ♡
- Comparison of Anthropometry, Bioelectrical Impedance, and Dual-energy X-ray Absorptiometry for Body Composition in Cirrhosis. (2022/03/01) ♡
- Spectrum of Neuroimaging Abnormalities in Brain in Patients of Acute-on-Chronic Liver Failure. (2022/03/01) ♡
- Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis. (2022/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. (2022/03/01) ♡
- Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies. (2022/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. XSSJS inhibits hepatic fibrosis by promoting the miR-29b-3p/VEGFA axis in vitro and in vivo. (2022/02/25) ♡
- Prognosis and Survival Modeling in Cirrhosis Using Parenclitic Networks. (2022/02/21) ♡
- Liver fibrosis alters the molecular structures of hepatic glycogen. (2022/02/15) ♡
- Interleukin 10 inhibits oxidative stress-induced autophagosome formation in hepatic stellate cells by activating the mTOR-STAT3 pathway. (2022/02/15) ♡
- Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. (2022/02/10) ♡
- Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States. (2022/02/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure. (2022/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Bioelectrical impedance vector analysis in patients on the waiting list for liver transplant: Associated factors and prognostic effects. (2022/02/01) ♡
- [Guidelines for the follow-up of pediatric patients with chronic liver disease]. (2022/02/01) ♡
- Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. (2022/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Clinical application and pharmacological mechanism of Wuling powder in the treatment of ascites: A systematic review and network pharmacological analysis. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fatty Liver Disease: Diagnosis and Stratification. (2022/01/27) ♡
- Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese: A Prospective Cohort Study. (2022/01/26) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Immunomodulatory Effect of Lycium barbarum Polysaccharides against Liver Fibrosis Based on the Intelligent Medical Internet of Things. (2022/01/25) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. [Clinical research of refractory ascites of cirrhosis treated with acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture]. (2022/01/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Kasai Operation in Biliary Atresia After Extensive Bowel Resection. (2022/01/24) ♡
- [Exploring the effects of artesunate and fuzheng huayu decoction on mitochondria in the treatment of schistosomiasis liver fibrosis]. (2022/01/20) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.